Cefuroxime Sodium is a second-generation parenteral cephalosporin with good Gram-positive and moderate Gram-negative coverage, extensively used for respiratory infections, surgical prophylaxis and Lyme disease. Simson Pharma's Cefuroxime Sodium reference standard and impurities support compendial testing for this widely used injectable beta-lactam.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cefuroxime Sodium Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.